Being creative by nature, I first decided to study marketing after my baccalaureate. I wanted to work in the world of packaging (cosmetics sector). I have always loved beauty products. Being able to create, draw, design, attracted me. I didn’t like the business school I chose at the time – I felt like I didn’t …
BOSTON and LAUSANNE, Switzerland, Feb. 11, 2021 /PRNewswire/ — SOPHiA GENETICS, a global leader in Data-Driven Medicine, has appointed Ross Muken as Chief Financial Officer (CFO). Mr. Muken brings more than 20 years of financial leadership experience with a strong focus on the medical technology and life sciences space. He joins the SOPHiA GENETICS team from Click Therapeutics where he served …
SOPHiA GENETICS Appoints Ross Muken as Chief Financial Officer Read More »
Our team at SOPHiA GENETICS has worked tirelessly over the past months to help advance the efforts of SARS-CoV-2 surveillance and research. During the first stages of the pandemic, we leveraged our experience in NGS to develop and fine-tune a robust solution to conduct full-genome analysis of SARS-CoV-2. Genotyping of the virus has been instrumental to …
Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine · SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader · Company demonstrates solidity of its business model with banks joining …
SOPHIA GENETICS RAISES $110 MILLION IN OVERSUBSCRIBED NEW FUNDING ROUND Read More »
Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more than 1,000 hospitals around the world to try to work out how the COVID-19 pandemic will evolve in the coming months and years. The data mining tool will be used to try to unearth some of the …
Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’ Read More »
São Paulo, Brazil, July 23, 2020: SOPHiA GENETICS, leader in Data-Driven Medicine, announced today the signature of a Trial Match agreement with Dasa, the largest medical diagnostic company in Latin America. The group chose the SOPHiA Platform to lead the region toward an extensive approach to Data-Driven Medicine powered by the world’s first integrated multimodal …
SOPHiA GENETICS, leader in Data-Driven Medicine, has been named Best Overall Genomics Company as part of the 2020 MedTech Breakthrough Awards. READ MORE
SOPHiA Whole Exome Solution (WES) now includes accurate CNV detection, making it a powerful application for healthcare professionals in their fight against rare diseases. Houston, Texas, USA – 18th October 2019: SOPHiA GENETICS, leader in Data-Driven Medicine, announced today at the American Society of Human Genetics Annual Meeting (ASHG) the release of the new version …
SOPHiA GENETICS Reaches New Analytical Heights with its Whole Exome Solution Read More »
Lausanne, Switzerland, and Boston, United States, September 19, 2019: SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Gaëtan Fraikin and Sergei Yakneen have joined its executive team as Chief Marketing Officer and Chief Information Officer, respectively. Mr. Fraikin and Mr. Yakneen bring decades of highly specialized experience from key players in the health tech industry. …